Stem Cell Therapy in Eye Diseases (Talk, 15 April 2022)

  • Duration: 1:19:17
  • Published:
  • Spoken language: Turkish
  • Watch on YouTube

About this video

This video is the roughly 1 hour 20 minute recording of the live broadcast of Acıbadem Kayseri Hospital on 15 April 2022, in which Prof. Dr. Ayşe Öner gave a presentation on "Stem Cell Therapy in Eye Diseases" and answered viewers' questions. The talk is in Turkish.

What does the video cover?

  • 1:24 Prof. Dr. Ayşe Öner explains that she has worked on stem cell applications in eye diseases for about 10 years, in cooperation with the Turkish Ministry of Health.
  • 2:49 What are stem cells? Embryonic and adult stem cells; embryonic stem cells are not permitted in Turkey, while adult (mesenchymal) stem cells are obtained from fat tissue, bone marrow and the umbilical cord; applications require approval from the Ministry of Health.
  • 5:46 How do stem cells work? The mesenchymal stem cells used do not bring dead cells back; they act as a supportive treatment, helping diseased cells function through the growth factors they release.
  • 7:13 Why is the eye, a small organ needing few cells, well suited to stem cell applications?
  • 8:14 Viewer questions: optic atrophy, light sensitivity, night blindness and dry macular degeneration; disease stage and level of vision matter more than age; the effect can decrease over time and the application can be repeated.
  • 16:46 Methods of application: injections into the eye and under the retina, and the suprachoroidal method, which does not enter the eye.
  • 18:37 Disease groups treated: retinitis pigmentosa, severe inherited retinal diseases starting in childhood, dry and juvenile inherited macular diseases, and some optic neuropathies.
  • 20:11 How families can notice night blindness in children; regular eye examinations for children; the role of electrophysiological tests and OCT in diagnosis.
  • 25:36 Applications are carried out with Ministry approval and reported regularly; treatment in children and better response at an early stage.
  • 26:39 What does the success rate mean? Not every patient responds, and miraculous expectations should be avoided.
  • 29:15 Ongoing laboratory research and teamwork.
  • 30:44 Viewer questions: eye transplantation, insurance coverage, lazy eye (amblyopia), differences in response between disease groups, and publications.
  • 40:14 Viewer questions: other retinal diseases, safety of the application, cell production and the day of the procedure.
  • 54:22 Lifestyle advice: harm of smoking, sun protection, diet and supplements, follow-up after the application.
  • 1:17:16 Closing: stem cell application is not a cure but a supportive treatment that gains time.

The video was published by Acıbadem Healthcare Group in 2022.

This content is for information only; please consult your physician for diagnosis and treatment.

More videos

Enquiry Form

For information and consultation requests, fill in the form or reach us by phone or WhatsApp.